Phyto-oestrogens and prostatic growth

National Medical Journal of India

Volumn 17, Issue 1, 2004, Pages 22-26

  Vij, Urmila ^a   Kumar, Anand ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5ALPHA PREGNANE 3,20 DIONE; ANTIBIOTIC AGENT; COUMESTROL; DAIDZEIN; DIETHYLSTILBESTROL; EQUOL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FINASTERIDE; FULVESTRANT; GENISTEIN; ISOFLAVONE DERIVATIVE; ISOFLAVONOID; LIGNAN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PHYTOESTROGEN; PROTEIN KINASE; PYGEUM AFRICANUM EXTRACT; RALOXIFENE; SABAL EXTRACT; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE BINDING GLOBULIN; SITOSTEROL; TAMOXIFEN; TESTOSTERONE; TYROSINE; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; ASIA; CANCER CELL; CANCER GROWTH; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CHEMOPROPHYLAXIS; DIET; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENCY; ENZYME INHIBITION; ERECTILE DYSFUNCTION; FEMINIZATION; GYNECOMASTIA; HORMONE DEPENDENCE; HUMAN; IMPOTENCE; LIBIDO DISORDER; MALE; MIGRATION; NONHUMAN; PROSTATE CANCER; RECEPTOR AFFINITY; REVIEW; SIDE EFFECT; VASCULAR DISEASE; VEGETARIAN DIET; WESTERN HEMISPHERE;

ASIAN CONTINENTAL ANCESTRY GROUP; CHEMOPREVENTION; DIET, VEGETARIAN; EMIGRATION AND IMMIGRATION; HUMANS; ISOFLAVONES; LIGNANS; MALE; PHYTOESTROGENS; PLANT PREPARATIONS; PROSTATIC NEOPLASMS; TESTOSTERONE;

EID: 1842788064     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Rose DP, Boyer AP, Wynder EL. International comparision of mortality rates for cancer of the breast, ovary, prostate and colon per capita fat consumption. Cancer 1986;58:2363-71.
2. Parkin DM. Cancers of the breast, endometrium and ovary: Geographic correlations. Eur J Cancer Clin Oncol 1989;25:1917-25.
3. Shimzu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963-6.
4. Kolonel LN. Variability in diet and its relation to risk in ethnic and migrant groups. Basic Life Sci 1988;43:129-35.
5. Hampstock J, Kavanagh JP, George NJ. Growth inhibition of prostate cell lines in vitro by phyto-oestrogens. Br J Urol 1998;82:560-3.
6. Colemann CI, Hebert JH, Reddy P. The effect of phytosterols on quality of life in the treatment of benign prostatic hyperplasia. Pharmacotherapy 2002;22:1426-32.
7. Castle EP, Thrasher JB. The role of soy phytoestrogens in prostate cancer. Urol Clin North Am 2002;29:71-81.
8. Zhou JR, Yu L, Zhong Y, Blackburn GL. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr 2003;133:516-21.
9. Messina MJ. Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr Rev 2003;61:117-31.
10. Gordon AE, Shaughnessy AF. Saw palmetto for prostate disorders. Am Fam Physician 2003;67:1281-3.
11. Vermeulen A, Verdonck L, Van der Straeten M, Orie N. Capacity of the TeBG in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J Clin Endocrinol 1969;29:1470-80.
12. August GP, Tkachuk M, Grumbach MM. Plasma testosterone-binding affinity and testosterone in umbilical cord plasma, late pregnancy, pre-pubertal children, and adults. J Clin Endocrinol Metab 1969;29:891-9.
13. Burton RM, Westphal U. Steroid hormone-binding proteins in blood plasma. Metabolism 1972;21:253-76.
14. Forest MG, Cathiard AM, Bertrand JA. Total and unbound testosterone levels in the newborn and in normal and hypogonadal children: Use of a sensitive radioimmunoassay for testosterone. J Clin Endocrinol Metab 1973;36:1132-42.
15. Lasnitzki I, Franklin HR. The influence of serum on uptake, conversion and action of testosterone in rat prostate glands in organ culture. J Endocrinol 1972;54:333-42.
16. Isaacs JT, Brendler CB, Walsh PC. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate. J Clin Endocrinol Metab 1983;56:139-46.
17. Vermeulen A. The physical state of testosterone in plasma. In: James VHT, Serio M, Martini L (eds). The endocrine function of the human testis. Vol. 1. New York: Academic Press; 1973:157-70.
18. Makela SR, Santi L, Salo SL, McLachlan JA. Phytoestrogen and partial estrogen agonists in the adult male mouse. Environ Health Perspect 1995;103 (Suppl. 7):123-7.
19. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991;16:43-52.
20. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1966;87:897-904.
21. Wang H, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994;42:1666-73.
22. Adlercreutz H. Phyto-estrogens and cancer. Lancet Oncol 2002;3:364-73.
23. Barrett J. Phytoestrogens: Friends or foes? Environ Health Perspect 1996;104: 478-82.
24. Whitten P, Lewis C, Naftolin F. A phytoestrogen diet induces the premature anovulatory syndrome in lactationally exposed female rats. Biol Reprod 1993;49:1117-21.
25. Pfeifer BL, Piram JF, Hamann SR, Klippel KF. PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer. Br J Urol Int 2000;85:481-5.
26. De la Taille A, Buttyan R, Hayek O, Bagiella E, Shabsigh A, Burchardt M, et al. Herbal therapy PC-SPES: In vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. J Urol 2000;164:1229-34.
27. Pirani JF. The effects of phytotherapeutic agents on prostate cancer: An overview of recent clinical trials of PC-SPES. Urology 2001;58 (Suppl 24):36-8.
28. Darzynkiewicz Z, Traganos F, Wu JM, Chens S. Chinese herbal mixture PC-SPES in treatment of prostate cancer. Int J Oncol 2000;17:729-36.
29. Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, et al. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 2000;18:3595-603.
30. Hsieh TC, Xiong W, Traganos F, Darzynkiewicz Z, Wu JM. Effects of PC-SPES on proliferation and expression of AR/PSA in androgen-responsive LNCaP cells are independent of estradiol. Anticancer Res 2002;22:2051-60.
31. Huggins C, Hodgee CV. Studies of prostatic cancer. The effect of castration on estrogen and androgen injection on serum phosphatase in metastatic carcinoma of the prostate. Cancer Res 1941;1:293-7.
32. Robertson CN, Robertson KM, Padilla GM, O'Brien ET, Cook JM, Kim CS, et al. Induction of apoptosis by diethylstilbestrol in hormone insensitive prostate cancer cells. J Natl Cancer Inst 1966;88:908-17.
33. Ahmed M, Choksy S, Chilton CP, Munson KW, Williams J. High dose intravenous oestrogen (fosfestrol) in the treatment of symptomatic, metastatic, hormone-refractory carcinoma of the prostate. Int Urol Nephrol 1982;30:59-64.
34. Bergan RC, Blagosklonny M, Dawnson NA. Significant activity by high dose tamoxifen in hormone refractory prostate cancer. Proc Am Soc Clin Oncol 1995;14:A637.
35. Bergan RC, Reed E, Myers CE, Headlee D, Brawley O, Cho HK, et al. A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer. Clin Cancer Res 1999;5:2366-73.
36. Wakeling AE, Dukes M, Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res 1991;51:3867-73.
37. Lau KM, Leav I, Ho SM. Rat estrogen receptor-α and β and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats. Endocrinology 1998;139:424-7.
38. Chang WY, Prins GS. Estrogen receptor-β: Implications for the prostate gland. Prostate 1999;40:115-24.
39. Montano MM, Jaiswal AK, Katzenellenbogen BS. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-α and estrogen receptor-β. J Biol Chem 1998;273:25443-9.
40. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci USA 1998;95:15677-82.
41. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Nat Acad Sci USA 2001;98:6330-5.
42. Horvarth LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, et al. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 2001;61: 5331-5.
43. Latil A, Bieche I, Vidaud D, Lidereau R, Berthon P, Cussenot O, et al. Evaluation of androgen, estrogen (ERalpha and ERbeta) and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res 2001;61:1919-26.
44. Lau KM, LaSapina M, Long J, Ho SM. Expression of estrogen receptor ER-alpha and ER-beta in normal and malignant prostatic epithelial cells: Regulation of methylation and involvement in growth regulation. Cancer Res 2000;60:3175-82.
45. Somjen D, Amir-Zaltsman Y, Gayer B, Kulik T, Knoll E, Stern N, et al. 6-carboxymethyl genistein: A novel selective oestrogen receptor modulator (SERM) with unique, differential effects on the vasculature, bone and uterus. J Endocrinol 2002;173:415-27.
46. Suzuki K, Koike H, Matsui H, Ono Y, Hasumi M, Nakazato H, et al. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int J Cancer 2002;99:846-52.
47. Sachell KD. Soy isoflavones - benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 2001;20:3545-25.
48. Gustafsson JA. Estrogen receptor β - getting in on the action? Nat Med 1997;3: 493-4.
49. Mousavi Y, Adlercreutz H. Genistein is an effective stimulator of sex hormone binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 1993;58:301-4.
50. Adlercreutz H, Hockerstedt K, Bannwart C, Bloigu S, Hamalainen E, Fotsis T, et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987;27:1135-44.
51. Aldercreutz H, Bannwart C, Wahala K, Makela T, Brunow G, Hase T, et al. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993;44:147-53.
52. Evans BM, Griffiths K, Morton MS. Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995;147:295-302.
53. Messina M, Barnes S, Setchell KD. Phyto-oestrogens and breast cancer. Lancet 1997;350:971-2.
54. Stephens FO. Phytoestrogens and prostate cancer: Possible preventative role. Med J Aust 1997;167:138-40.
55. Bergan R, Kyle E, Nguyen P, Trepe J, Ingui C, Neckers L. Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin. Clin Exp Metastasis 1996;14:389-98.
56. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262: 5592-5.
57. Bonham M, Arnold H, Montgomery B, Nelson PS. Molecular effects of the herbal compound PC-SPES: Identification of activity pathways in prostate carcinoma. Cancer Res 2002;62:3920-4.
58. Peterson G, Barnes S. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 1993;22:335-45.
59. Suzuki Y, Kondo Y, Himeno S, Nemoto K, Akimoto M, Imura N. Role of antioxidant systems in human androgen-independent prostate cancer cells. Prostate 2000;43:144-9.
60. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 2001;61:6777-82.
61. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001;131 (4 Suppl): 1362S-1375S.